The nation of Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) over five years because of Washington's demand for sensitive information.
The decision came to light after a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesman has since clarified that the United States was requesting health data for scientific study and commercial gain but was not willing to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged continued negotiations to reach a deal agreeable to both sides so the country's critical HIV treatment initiative can proceed.
Wider Background
This rejection comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were raised about the safety of Kenyans' medical information.
After returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to similar agreements, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"In essence, our nation would provide the raw materials for scientific discovery without any certainty that the end products would be accessible to our citizens should a future pandemic arise."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems already established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This system is designed to ensure that when a nation contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent co-operation might be designed in a way that respects the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that negotiations should continue given that much of the nation's Aids initiatives relied on international support.
"If specific concerns arise, including those involving data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," the group added.
The situation highlights the complex debate between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.